Picoplatinisananalogofcisplatinwitha2-methylpyridineligandthatdisplaysanticancerchemotherapeuticactivity.Picoplatinisusedtotreatnon-smallcelllungcancer(NSCLC)andisinclinicaltrialsasapotentialtreatmentforprostatecancer.PicoplatinintercalateswithGpGsequencesinDNAandshowsefficacyinhibitingtumorgrowthinvitro,invivo,andinclinicalsettings.
| CasNo. | 181630-15-9 |
|---|---|
| Purity | ≥98% |
| Formula | C6H10Cl2N2Pt |
| FormulaWt. | 376.15 |
| ChemicalName | azane;2-methylpyridine;platinum(2+);dichloride |
| IUPACName | azane;2-methylpyridine;platinum(2+);dichloride |
| Appearance | Whitetopaleyellowpowder |
| StoreTemp | -20°C |
|---|---|
| ShipTemp | Ambient |
| InfoSheet | P3210InfoSheetPDF |
|---|
MatosCS,deCarvalhoAL,LopesRP,etal.Newstrategiesagainstprostatecancer--Pt(II)-basedchemotherapy.CurrMedChem.2012;19(27):4678-87.PMID:22856665.
EckardtJR,BentsionDL,LipatovON,etal.PhaseIIstudyofpicoplatinassecond-linetherapyforpatientswithsmall-celllungcancer.JClinOncol.2009Apr20;27(12):2046-51.PMID:19289620.
KanzawaF,AkiyamaY,SaijoN,etal.Invitroeffectsofcombinationsofcis-amminedichloro(2-methylpyridine)platinum(II)(ZD0473)withothernovelanticancerdrugsonthegrowthofSBC-3,ahumansmallcelllungcancercellline.LungCancer.2003Jun;40(3):325-32.PMID:12781432.
MunkVP,DiakosCI,EllisLT,etal.InvestigationsintotheinteractionsbetweenDNAandconformationallyconstrainedpyridylamineplatinum(II)analoguesofAMD473.InorgChem.2003Jun2;42(11):3582-90.PMID:12767196.
